CN101610718B - Device and method for automatic data acquisition and/or detection - Google Patents
Device and method for automatic data acquisition and/or detection Download PDFInfo
- Publication number
- CN101610718B CN101610718B CN2008800051491A CN200880005149A CN101610718B CN 101610718 B CN101610718 B CN 101610718B CN 2008800051491 A CN2008800051491 A CN 2008800051491A CN 200880005149 A CN200880005149 A CN 200880005149A CN 101610718 B CN101610718 B CN 101610718B
- Authority
- CN
- China
- Prior art keywords
- medical treatment
- treatment device
- data
- information
- temporal information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Abstract
Methods and devices for providing diabetes management including automatic time acquisition protocol is provided.
Description
Technical field
The application requires to submit on February 15th, 2007 be entitled as " Device And MethodFor Automatic Data Acquisition And/Or Detection " the 60/890th, No. 154 U.S. Provisional Patent Application and on February 14th, 2008 submit to be entitled as " Device AndMethod For Automatic Data Acquisition And/Or Detection " the 12/031st, the disclosure of each is incorporated into this and is used for all purposes with them for the priority of No. 664 U.S. Patent applications, the mode by reference.
Background technology
In diabetes management, there is a kind of device that allows the diabetics measurement of glucose levels.A kind of such device is the handheld electronic instrument such as blood glucose meter, such as from the Abbott Diabetes Care company of my Mi Da of California
Blood glucose monitoring system, it receives blood sample via the test strip based on enzyme.Typically, the patient cuts finger or interchangeable body position to obtain blood sample, and the blood sample of extracting out is put on test strip, and this test strip is inserted in the test strip opening or port in this meter case.The current conversion that blood glucose meter produces the enzyme reaction in the test strip is corresponding blood glucose value, and this blood glucose value is shown or otherwise offer the blood sugar level of patient so that test to be shown.
This periodic discontinuous blood sugar test helps corrective action that diabetics takes any necessity with management of diabetes situation better.Limited functional (for example, provide and utilize the measured blood glucose value of test strip also these data to be stored for follow-up memory or demonstration) is provided available blood glucose meter at present, and do not provide any extraneous information or ability with the assisting patients management of diabetes.
Summary of the invention
According to each embodiment of disclosure file, a kind of predefined parameter that is associated for detection of the operating conditions with the analyte monitoring device is provided, in response to predefined parameter detects delivery time information request and in response to the method and apparatus of the request receiving time information that transmits.
These or other purpose, the feature and advantage of disclosure file will become apparent more all sidedly from following detailed description, claims and the accompanying drawing of embodiment.
Description of drawings
Fig. 1 is the block diagram that illustrates for the treatment management system of an embodiment who realizes disclosure file;
Fig. 2 is the block diagram of the fluid transfer apparatus of the Fig. 1 among the embodiment of disclosure file;
Fig. 3 is the flow chart that step is detected in the time zone in the treatment management system that illustrates among the embodiment of open file;
Fig. 4 is the flow chart that step is detected in the time zone in the treatment management system that illustrates among another embodiment of disclosure file;
Fig. 5 is the flow chart of the device synchronizing step in the treatment management system that illustrates among the embodiment of disclosure file;
Fig. 6 is the flow chart of the device condition notification function in the treatment management system that illustrates among the embodiment of disclosure file;
Fig. 7 is the flow chart such as the automatic time information detection functions of institute's combination in the medical treatment device of blood glucose meter that illustrates among the embodiment of disclosure file;
Fig. 8 is the flow chart such as the automatic time information detection functions of institute's combination in the medical treatment device of blood glucose meter that illustrates among another embodiment of disclosure file; And
Fig. 9 A-9C illustrates the embodiment according to the automatic expired detection of blood glucose meter test strip of embodiment of disclosure file.
The specific embodiment
As described below, in the scope of disclosure file, provide and various parts or the operation of the device user interface feature that be associated for the treatment of in the management system, such as the function that changes based on automatic time, to the automatic expiration date of test strip detect, in (for example) treatment management system each parts synchronously, change, be used for and the informing function of the programmable event that the treatment management is associated and the voice-enabled communication between a plurality of devices for the treatment of management system based on user configured user interface.
Fig. 1 is the block diagram for the treatment management system of an embodiment who realizes disclosure file.With reference to Fig. 1, treatment management system 100 comprises analyte monitoring system 110, and it is operably connected to fluid transfer apparatus 120, and fluid transfer apparatus then is operably connected to remote terminal 140.As shown in the drawing, in one embodiment, analyze monitoring system 110 and be connected to patient 130 with monitoring or measure patient's analyte level.And conduit and injection device that fluid transfer apparatus 120 utilizes (for example) to be connected to the intubate (not shown) are connected to the patient, and wherein intubate is placed so that medicine (such as being example with the insulin) is inputed to the patient by patient's skin percutaneous.
With reference to Fig. 1, the analyte monitoring system 110 among embodiment can comprise one or more analyte sensors, and these analyte sensor percutaneous are placed and made at least a portion of analyte sensor contact with patient's analyte maintenance fluid.Analyte sensor can include but not limited to the analyte sensor of short term subcutaneous analyte sensor or process skin, and for example, it is configured to detect the analyte level of the patient in the predetermined period, and after that, need reappose this sensor.
One or more analyte sensors of analyte monitoring system 110 are connected respectively to the one or more of data transfer unit, data transfer unit is configured to receive from the one or more signals corresponding to each analyte sensor of this patient's detected analyte level, and will send acceptor device to corresponding to the information of detection analyte level, and/or fluid transfer apparatus 120.Namely, by communication link, translator unit can be configured to periodically and/or will send to the data that detected analyte level is associated off and on and repeatedly one or more other devices (such as fluid transfer apparatus and/or remote terminal 140) and be used for further date processing and analysis.
In one aspect, in one or more acceptor devices of analyte monitoring system 110 and fluid transfer apparatus each comprises user interface elements, and user interface elements can comprise display unit, automatic output unit (such as being example with the speaker) or be used for showing or notifying any other user interface mechanisms of the user of these devices.
In one embodiment, the translator unit of analyte monitoring system 110 can be configured to, after the data relevant with analyte that receive from the respective analyte sensor, substantially in real time the data relevant with analyte are sent to fluid transfer apparatus 120 and/or remote terminal 140, thereby can be monitored in real time such as the analyte level of patient 130 blood sugar level.In one aspect, patient's analyte level can utilize one or more discrete blood sugar test sets (such as the blood glucose meter that adopts test strip for blood-sugar) or continuous analyte monitoring system (such as the continuous blood sugar monitoring system) to obtain.In a further embodiment, analyte monitoring system 110 can comprise such as can be from California the FreeStyle that obtains of the Abbott Diabetes Care company of my Mi Da and the blood glucose meter of Precision instrument.This blood glucose meter can be used for the sensor of analyte monitoring system 110 is calibrated.At (for example) U.S. Patent number 6,134,461,6,175,752,6,121,611,6,560,471,6,746,582 and other places in adoptable exemplary analyte system has been described, the open file of these United States Patent (USP)s is incorporated into this by the mode of reference.
The analyte that can monitor in analyte monitoring system 110, determine or detect comprises (for example) acetylcholine, amylase, diabetes associated peptide, bilirubin, cholesterol, chorionic gona dotropin, creatine kinase (for example, CK-MB), the measurement of sarcosine, DNA, fructosamine, glucose, glutamate, Glu, growth hormone, hormone, ketone, lactate, oxidative pressure (such as 8-iso PGF2 gamma), peroxide, prostate special antigen, haemoglutinin, RNA, the thyroid hormone of promotion and troponin.Can also determine drug concentrations, these medicines such as (for example) antibiotic (for example, gentamycin, vancomycin etc.), biguanide, Digitoxin, different hydroxyl Digitoxin, drug dependence, GLP-1, insulin, PPAR analeptic, sulfonylureas, theophylline, thiazolidinedione and warfarin.
And in the scope of disclosure file, the translator unit of analyte monitoring system 110 can be configured to directly with remote terminal 140 or fluid transfer apparatus 120 in one or more communication.In addition, in the scope of disclosure file, can provide other devices to be used for communicating with analyte monitoring system 100, these devices comprise additional receptor/data processing unit, remote terminal (be example such as terminal and/or bedside terminal with the doctor in the hospital environment).
In addition, in the scope of disclosure file, one or more can being configured in analyte monitoring system 110, fluid transfer apparatus 120 and the remote terminal 140 communicates by wireless data communication link, wireless data communication link connects such as, but not limited to the suitable radio communication of any other types between RF communication link, bluetooth communications link, infrared communication link or the two or more electronic installation, and it can carry out unidirectional or two-way communication further between two or more devices.Replacedly, data link can comprise that wired cable connects, such as (for example) but be not limited to that RS232 connects, USB connects or the series connection cable connects.
In one embodiment, fluid transfer apparatus 120 can include but not limited to outside injection device, such as external insulin injection pump, implantable pump, pen type insulin injection device, stuck pump, be used for suction-type injection device that the nose insulin transmits or the suitable transmission system of other types arbitrarily.In addition, in one embodiment, remote terminal 140 can comprise the mobile phone that (for example) desktop PC terminal, data communication enable information booth, laptop computer, hand-held computing device (such as personal digital assistant PDA) or data communication enable.
Refer again to Fig. 1, in one embodiment, analyte monitoring system 110 comprises the bar port, and this port is configured to hold test strip and is used for the capillary blood glucose test.In one aspect, in addition, utilize the measured blood sugar level of test strip can be configured to provide the periodic calibration of analyte sensor of analyte monitoring system 110 to guarantee and to improve the accuracy of the detected analyte level of analyte sensor.
Refer again to Fig. 1, in an embodiment of disclosure file, fluid transfer apparatus 120 can be configured to comprise voice signal activation/generating unit, be used for carrying out voice communication with the remote terminal 140 that is configured to voice device remote terminal such as mobile phone, voice-enabled personal digital assistant, blackberry device (Blackberry device) etc.For example, in one embodiment, communication between fluid transfer apparatus 120 and the remote terminal 140 can be based on voice, makes to output to the phone that user's data or information are configured to be sent to the user from fluid transfer apparatus 120.Conversely, fluid transfer apparatus 120 can be configured to receive from being configured to phone or the voice command of the remote terminal 140 of other voice signal communicators (such as the PDA with voice signal ability or personal computer) arbitrarily extraly.
In this mode, in one embodiment, the user interface of fluid transfer apparatus 120 can be configured to have voice signal activation/generating unit, thereby is converted into voice signal and is transmitted to the remote terminal 140 that voice signal enables for user's output information.For example, when fluid transfer apparatus 120 detects alarm condition, the phone (remote terminal 140) that fluid transfer apparatus 120 is configured to the user starts a call, and when the user has connect this telephone wire, provides the voice signal of this alarm condition of expression to the user.
In a further embodiment, at specific predetermined patient situation, except the user to fluid transfer apparatus 120 starts a call or the user to fluid transfer apparatus does not start a call, and fluid transfer apparatus 120 can be configured to directly start a call to health care doctor, local hospital or emergency medical facility.
In addition, in the scope of disclosure file, can come exclusively by the subscriber phone that carries out voice communication with fluid transfer apparatus 120 or part is carried out the mutual or programming of fluid transfer apparatus 120 exclusively.Namely, when the user wishes that carbohydrate in the Fluid Computation transfer device 120 is injected, the user can utilize user's phone (remote terminal 140) to dial predetermined number being connected with this fluid transfer apparatus 120, and this user can connect via user's phone (remote terminal 140) and the phone between the fluid transfer apparatus 120 voice command is offered fluid transfer apparatus 120.
Fig. 2 is the block diagram of the fluid transfer apparatus among the embodiment of disclosure file.With reference to Fig. 2, the fluid transfer apparatus 120 among embodiment comprises processor 210, and processor is operably connected to memory element 240, input block 220, display unit 230, output unit 260, and fluid delivery element 250.In one embodiment, processor 210 comprises microprocessor, this microprocessor be configured to and can by control and/or the visit fluid transfer apparatus 120 each parts in each control the function of fluid transfer apparatus 120.In one embodiment, can provide a plurality of processors to provide redundant as safety measure and under the situation that single processor breaks down.In addition, can be between a plurality of processor units of fluid transfer apparatus 120 the shared processing ability, make and can carry out pumping function and/or control faster and more accurately.
Refer again to Fig. 2, the input block 220 that may be operably coupled to processor 210 can comprise fine motion dialing keyboard button, Trackpad screen or other are used for providing to fluid transfer apparatus 120 the suitable input mechanism of input command arbitrarily.For example, more specifically, under the situation of fine motion dialing input equipment or Trackpad screen, the patient of fluid transfer apparatus 120 or user can handle each fine motion dialing or Trackpad in conjunction with the display unit 230 of not only carrying out the data input but also carrying out data output.Display unit 230 can comprise sensing contact screen, lcd screen or be used for the suitable display unit of any other types of fluid transfer apparatus 120, and this unit is configured to show the graphical presentation (such as the chart or the figure that are associated with the trend data of institute's monitor blood glucose level in insulin charge velocity, one period) of alphabet data and pictorial information (such as the icon that is associated with one or more predetermined states of fluid transfer apparatus 120) or data or the text notification of giving the patient.
In one embodiment, the letter representation that shows at display unit 230 can be configured to change by the user of fluid transfer apparatus, makes the size of shown numeral and character can be adjusted to the vision needs that are fit to the user.For example, in one embodiment, the user can use font size adjustment request via input block 220 and change numeral shown on the display unit 230 and the size of character with instruction processorunit 210.In one aspect, the character boundary of shown each character, value or word can increase or reduce on the display unit 230.For example, replacedly, can be under the control of processor 210 the font size adjustment all be applied to all outputs and arranges, thereby the user that size is adjusted arranges basic value or the characters that all show on the display unit 230 that can be configured to be applied to fluid transfer apparatus 120 (Fig. 1).
And, refer again to Fig. 2, aspect other of disclosure file in, can determine the relative size adjustment of shown character or value by processor 210, make the relative size adjustment to be embodied as in display unit 230 enterprising line outputs to show.In this mode, in one embodiment, depend on type or the configuration (no matter being that bitmap or icon type show) of display unit 230, can in the predetermined size limit of each value or character, realize showing size adjustment.For example, being assigned to 10% the relative increase of font size of the viewing area of insulin dose level can be corresponding to 5% relative increase of the size that is assigned to the viewing area that the insulin passing time shows.In one embodiment, processor 210 can be configured to determine that based on the size adjustment of user's input each regional relative size of display unit 230 changes, suitably to use the relative size discrepancy adjustment.
Further, processor 210 can be configured to increase the font size that is presented on the display unit 230 based on the order of user's input temporarily, makes only to realize that at display screen the size that the user on the display unit 230 asks changes when processor 210 receives user's input command of size adjustment.In this mode, processor can be configured to when the user no longer watches the user to ask the particular screen curtain of font size adjustment, to get back to display unit 230 before the demonstration size of programming arrange.
In addition, the user interface of the receiving element of 110 (Fig. 1) can be configured to have similar big or small adjustment capability in the analyte monitoring system, indicates shown character on the controller of analyte detection system 110 or the display unit that processor is suitably adjusted analyte monitoring system 110 or the size of value to allow the user.
In a further embodiment, display unit 230 can be configured to show insulin or fluid transfer apparatus 120 employed other drugs (such as, secrete with Pramlintide (symlin) and hundred that to reach (byetta) be example) indication or the labelling of type.In one embodiment, a kind of like this labelling can be associated with the predetermined icon or the character that are used for being presented on the display unit 230.In addition, in the scope of disclosure file, the information that is associated with shown labelling or indication can be stored in the memory element 240, makes the user can retrieve this information in needs.In addition, can be in fluid transfer apparatus 120 (Fig. 1) at an indication of shiftwork programming or a labelling, make and utilize the shiftwork person of fluid transfer apparatus 120 can be according to command aligning daytime and the evening based on these labellings.
For example, if the user on Monday with the Tuesday of night job and in the work of Thursday and day shift Friday, then can in fluid transfer apparatus 120, store, identify or the labelling pattern-information of should working every day, so that extra data management function and more powerful treatment analysis to be provided.For example, can arrange the mealtime (for example, the point in the mornings 9 of 8 Tuesdays of the morning on Monday) (during night shift) such as breakfast, wherein breakfast is at the point in the mornings 8 of at 7 in the morning and the Friday of Thursday.In this mode, the user can operate the data relevant with have a meal (for example, breakfast) of access easily and the treatment information that is associated in conjunction with convection cell transfer device 120.This can help the user to improve user's diet, such as every day food obtain.
With reference to Fig. 2, the subscriber unit 260 that is operably connected to processor 210 can comprise the warning that can listen or comprise one or more tones and/or the warning of pre-programmed or programmable tone or audio fragment or have one or more pre-programmed or the vibrations alerts feature of programmable vibrations alert level.
In addition, in an embodiment of disclosure file, each alarm events or alert event can be programmed to have the combination notification feature, make to depend on the importance rate that is associated with each alarm or warning that vibrations are indicated, can be listened indication or show that the combination of indication can be provided for the user who uses this display unit 230 that combines this output unit 260.
For example, processor 210 can be configured to, except at the one or more predetermined alarm that needs the user to note immediately and the bias light that intermittently glimmers on the display unit 230, also provide the vibrations of combination and the audible alarm of raising gradually at output unit 260.An example can comprise that the accidental pressure in the insulin conduit increases, and this can indicate the obstruction that should be notified to the user immediately or the situation that other are not expected.Processor 210 can be configured to not reaffirm this alarm or warning in the given time automatically under the user removes the situation of this be associated alarm or alarm condition.In addition, each alarm/alarm feature can be programmed for separately and be comprised that wideer tone selects, can listen grade, shockproofness and visual display intensity.
Further, fluid transfer apparatus 120 can be configured to provide the alarm that is associated with temperature change or the indication of reporting to the police.That is, when the fluid transfer apparatus 120 experience temperature that comprise insulin (for example, insulin being included in the liquid reservoir) rose or descend, the change on this temperature may have adverse effect to the islets of langerhans that is included in the device 120.Therefore, temperature sensor can be connected on the processor 210 of fluid transfer apparatus 120, operating conditions with test fluid transfer device 120, and when (for example) temperature change reaches the effect that may align the insulin of transmission potentially the predetermined threshold level of adverse effect is arranged, the change on the temperature is notified to the user.
In Fig. 2, also show fluid delivery element 250, this fluid delivery element is operably connected to processor 210, and be configured to, with insulin medicament or amount from the insulin liquid reservoir or arbitrarily the appropriate containers (not shown) of other types (this container is used for transmitting via the injection device of the sleeve pipe that is connected to the subcutaneous placement under the patient skin insulin of fluid transfer apparatus 120) pass to the patient.
Also with reference to Fig. 2, memory element 240 can comprise random-access memory (ram), read only memory (ROM) or arbitrarily the other types data storage cell (its be configured to store for by processor 210 accesses and carry out with control fluid transfer apparatus 120 and/or based on from analyte monitoring system 110, remote terminal 140, patient 120 or arbitrarily the received data of other input data sources carry out programmed instruction and the data of date processing) one or more.
Fig. 3 is the flow chart that step is detected in the time zone in the treatment management system that illustrates among the embodiment of disclosure file.With reference to Fig. 3, fluid transfer apparatus 120 (Fig. 1) can be configured to send the location position requests to (for example) global positioning system (GPS).Afterwards, the processor 210 by fluid transfer apparatus 120 receives location message.Processor 210 is configured to further determine whether location message changes.Namely, in one embodiment, processor 210 is configured to received location message (this information can comprise the current time-zone information that is associated with the location of fluid transfer apparatus 120) time-zone information with operation of storage in the fluid transfer apparatus 120 is compared.
Referring again to, if determine that location message does not change, then routine stops.On the other hand, change if determine the location message of fluid transfer apparatus, then for example on display unit 230, location change information is exported to the user.Afterwards, processor 210 can be configured to generate user prompt or the notice of the time-zone information that changes fluid transfer apparatus 120, makes to be updated to the new location that fluid transfer apparatus 120 is just turning round.
For example, when fluid transfer apparatus 120 is programmed to have based on time and the predetermined basis profile that is associated with the internal clocking of fluid transfer apparatus 120 and/or injects function, can expect to change some or all in the time-based insulin transmission profile of programming in the fluid transfer apparatus 120, with the location corresponding to fluid transfer apparatus 120.More specifically, when wherein having passed through one or more time zone if the user moves to another location from first location, for example, to Paris, for example, poor, mealtime preset time and the length of one's sleep will change the mode by example from Sheng Folang Sysco.In this case, the time-based insulin that can expect to change pre-programmed transmits profile, thus they and customer incident synchronised such as mealtime and the length of one's sleep.
Refer again to Fig. 3, in one embodiment, the user makes response to the time-based routine change prompting that processor 210 provides, processor 210 can be configured in one embodiment then, before realizing transmitting the change of profile and be associated arbitrarily alarm or notice, propagate the time change that is associated with the insulin transmission profile of pre-programmed and notify the user to confirm this change.For example, with the special time in a day (for example programmed the user, the noon of every day) locates to note a.p to inject under definite situation, processor 210 is configured in one embodiment, change the internal clocking of fluid transfer apparatus 120, perhaps replacedly change for injecting definite alarm of programming, so that response is made in the new location of user and fluid transfer apparatus 120.
In another embodiment, fluid transfer apparatus 120 can be configured to comprise the time zone detecting unit, can be configured to (for example change testing agency with the geographical location that is operably connected to processor 210 such as (for example) processor 210, atomic clock) communicates, detect step to carry out time zone described in conjunction with Figure 3.In addition, analyte monitoring system 110 can be configured to comprise aforesaid time zone detecting unit, with based on predetermined process or automatically detect any location change be associated with analyte monitoring system 110.In this mode, analyte monitoring system 110 can be configured to, and realizes temporarily the change of the function that is associated with analyte monitoring system 110 that is associated with the information of time in one day automatically or based on the pre-programmed step.
Fig. 4 is the flow chart that step is detected in the time zone in the treatment management system that illustrates among another embodiment of disclosure file.With reference to Fig. 4, fluid transfer apparatus 120 (Fig. 1) can be configured to, and sends the location position requests to (for example) global positioning system (GPS).Afterwards, the processor 210 by fluid transfer apparatus 120 receives location message.Processor 210 is configured to further determine whether location message changes.Namely, in one embodiment, processor 210 is configured to received location message (this information can comprise the current time-zone information that is associated with the location of fluid transfer apparatus 120) time-zone information with operation of storage in the fluid transfer apparatus 120 is compared.
Referring again to, if determine that location message does not change, then routine stops.On the other hand, change if determine the location message of fluid transfer apparatus 330, then for example processor 210 is configured to the one or more time-based programing functions of retrieval from the memory element 240 of fluid transfer apparatus 120 in one embodiment.
Afterwards, processor 210 can further be configured to change the time-based programing function that retrieves according to received location change information.Then, before processor 210 was carried out the function that retrieves of this change, the function that retrieves after will changing on the display unit 230 offered the user, for example, and to ask the affirmation of time-based adjustment.
In addition, in an embodiment of disclosure file, fluid transfer apparatus 120 can be configured to detect and save time daytime, and processor 210 can be configured to, the time of automatically carrying out the internal clocking of fluid transfer apparatus changes, and/or provide to accept the user notification of this time-based change, make the operation of upgrading the time-based program of fluid transfer apparatus 120 execution with any time-based change in insulin transmission system 120 operating conditions.
In the scope of disclosure file, fluid transfer apparatus 120 can be configured to from provide based on on-site update time information any navigation system receive location message.Fluid transfer apparatus 120 can be configured to have the location transceiver, and this transceiver is configured to send the location message request to for example satellite network, and receives location message from satellite network.
Replacedly, fluid transfer apparatus 120 can be configured to, according to its location message of local update synchronously of another device of (or new place be located in) running in this locality.This can comprise the host terminal that can be connected to fluid transfer apparatus 120, (this device has the ability of communicating by letter with fluid transfer apparatus 120 such as (for example) remote terminal 140 (Fig. 1), analyte monitoring system 110 or any other electronic installations of turning round in this new location, this the device such as, cell phone, personal digital assistant etc.).
In addition, in the scope of disclosure file, can make analyte monitoring system 110 also be configured to receive the change of new location message and any time-based programing function of corresponding execution with offering analyte monitoring system 110 in conjunction with Fig. 3-4 (it is associated with the corresponding change that location in the fluid transfer apparatus 120 changes information and time-based preprogrammed functions) described step and processing.
Fig. 5 is the flow chart of the device synchronizing step in the treatment management system that illustrates among the embodiment of disclosure file.With reference to Fig. 5, in one embodiment, fluid transfer apparatus 120 (Fig. 1) can be configured to detect from the synchronization request such as another device of remote terminal 140 or analyte monitoring system 110 (Fig. 1).Afterwards, between fluid transfer apparatus 120 and this synchronization request device, establish a communications link.In one embodiment, fluid transfer apparatus 120 can be configured to verify reliability and the identity of asking synchronous device, and when agreement was synchronous, fluid transfer apparatus 120 was configured to communicate by letter with this synchronization request device foundation.
In addition, in the scope of disclosure file, fluid transfer apparatus 120 can be configured to periodically or establish a communications link for synchronously with predetermined time interval and for another device.Replacedly, fluid transfer apparatus can be configured to, and when when detecting for synchronous another device in the on-site preset range of fluid transfer apparatus 120, attempts communicating to connect.
Refer again to Fig. 5, in one embodiment, fluid transfer apparatus 120 is configured to send its programming to be connected device with operation setting, and the device that this connects is configured to upgrade and store the data that receive from fluid transfer apparatus 120 based on predetermined condition.For example, predetermined condition can comprise and the pre-defined rule set that the data updated type is associated of wanting from fluid transfer apparatus 120, and injects the programing function (such as injecting any other information that calculating, interim basic profile, the basic profile of programming, insulin utilize level and is associated with this user) of relevant information, fluid transfer apparatus 120 such as history.
In this mode, in an embodiment of disclosure file, fluid transfer apparatus 120 arranges and the periodic synchronous of function can be synchronous with another device, make that when the user changes fluid transfer apparatus 120 fluid transfer apparatus after the new or renewal can be easily and is programmed to this user's specification easily.Above-mentioned can be configured to synchronously, at regular intervals (such as, weekly, once a day) periodically, when satisfying specific predetermined standard time (when being in the preset distance each other when device) and/or during in user command, carrying out.
In addition, in the scope of disclosure file, fluid transfer apparatus 120 can be configured to have random communication protocol, and this communication protocol will allow to carry out transfer of data between fluid transfer apparatus 120 and synchronizer.This can comprise wired or wireless communication, comprises for for example Bluetooth protocol, 801.1x agreement, the connection of USB line etc.
Fig. 6 is the flow chart of the device condition notification function in the treatment management system that illustrates among the embodiment of disclosure file.With reference to Fig. 6, fluid transfer apparatus 120 can be configured to the detection notice situation.For example, processor 210 interval (such as being example with per approximately 24 hours) that can be configured to pre-programmed detects this notice situation.Afterwards, detect the profile of the programming that is associated with this situation.An example of the profile of the programming that is associated with this situation comprises starting the user to be reminded whole night fast.
Refer again to Fig. 6, processor 210 among embodiment is further configured the message that is associated with notice situation and/or the programming profile that retrieves for generating, and on one or more in display unit 230 or output unit 260 message that generates is offered the user.In this mode, in an embodiment of disclosure file, fluid transfer apparatus 120 can be programmed to have the automatic prompting for situation, improves the insulinize management with assisting users.
In one embodiment, can skip the notice condition detection, and processor 210 can be configured to retrieve based on the user program of fluid transfer apparatus 120 profile of the suitable programming that is associated with the notice situation.In addition, be described as example although will remind fast whole night, the relevant prompting of any other treatment of can programming or device operating conditions are reminded, and are used for carrying out to remind the user by processor 210.The example of this prompting includes but not limited to that injection device is changed and reminded, battery altering is reminded, data sync is reminded, insulin replenishes prompting, blood sugar test prompting etc.In addition, in the scope of disclosure file, step described in conjunction with Figure 6 can be bonded in the analyte monitoring system 110, is used for the suitable automatic prompting of programming, replaces prompting, pick up calibration prompting etc. such as (for example) sensor.
Fig. 7 is the flow chart such as the automatic time information detection functions of institute's combination in the medical treatment device of blood glucose meter that the analyte monitoring system 110 among the embodiment of disclosure file is shown.With reference to Fig. 7, for example when the start step of the medical treatment device (such as blood glucose meter) that starts by the user detects the medical treatment device state of activation (710), call routine to obtain agreement automatic start-up time by the processor of medical treatment device.Namely, when medical treatment device is started shooting, this device be automatically configured into, time of implementation is obtained agreement will be wherein the request of time and/or date and time information be sent to available communication channel, and when receiving this information, storage in this medical treatment device, upgrade and/or otherwise arrange and/or show time/date and time information received or that get access to (720-740).
Refer again to Fig. 7, in one embodiment, at step 730 place receiving time information, and after, store received temporal information and/or show received temporal information at the display unit of medical treatment device.In one aspect, medical treatment device be configured to upgrade storage before all information association in time (for example, this sky (or week, month or other periods arbitrarily) middle particular moment the glucose readings obtained).More specifically, in one embodiment, when the medical treatment device that activated by the user such as blood glucose meter, the processor of blood glucose meter or controller are configured to enable or the activationary time/date receptor communication component of the RF transceiver of the processor that is connected to blood glucose meter (for example, such as).In one embodiment, time/the date receptor is configured to when activating automatically one or more utilization the in scope and seeks the communication network or acquisition time and date and time information.For example, time/the date receptor can be configured to, and utilizes the frequently short or FM belt length wave frequency of AM band, and the one or more radio frequency detection time/date and time information on public, government or the privately owned wave band.Replacedly, as mentioned above, can be from HA Global Positioning Satellite and medical treatment device time/cellular phone network (such as GSM, CDMA, AMPS etc.) in the scope of date receptor receives current local zone time/date and time information.In addition, if available and be in the scope, then the WiFi network can be used to time of reception/date and time information.
In this mode, in one embodiment, can be configured to automatic acquisition time information such as the medical treatment device of blood glucose meter, this temporal information is broadcasted on the frequency that antenna and the receptor of blood glucose meter is configured to turn round continuously.For example, when obtaining or verified this time and date information, upgrade or adjust internal clocking function or parts with accessed time/date and time information, and internal clocking function or parts are displayed to the user.
In a further embodiment, medical treatment device such as blood glucose meter can be configured to, with the fiducial time of GMT time as the All Log Entries that is associated with each data of storing in this medical treatment device (for example, being used for each performed blood sugar test) timestamp.Afterwards, this medical treatment device can be configured to, and based on the location of this medical treatment device, the temporal information based on GMT of storing of each journal entries that will store for this medical treatment device is converted to local zone time.
Fig. 8 is the flow chart such as the automatic time information detection functions in the medical treatment device of blood glucose meter of being combined in that illustrates among another embodiment of disclosure file.With reference to Fig. 8, in one embodiment, based on detecting the parameter one or more changes or pre-configured that is associated with the user of medical treatment device and/or medical treatment device, obtain agreement and start automatic time.For example, this device parameter can comprise the pre-configured time, this pre-configured time be used for time and date information periodic test (such as, every 24 hours, 48 hours or based on the calendar of programming, change with the compensation daylight saving time).
Replacedly, this device parameter can comprise that the environmental aspect that is associated with medical treatment device or user changes, such as detect the medical treatment device location during flight or motoring.That is, in one embodiment, this medical treatment device can be configured to comprise altimeter, and the processor that this altimeter is connected to medical treatment device detects medical treatment device on-site height above sea level as the user of this medical treatment device at the flight whilst on tour with (for example).In this case, this medical treatment device can be configured to obtain start-up time agreement to confirm or to verify the time and date information of medical treatment device.
In addition, this medical treatment device can comprise accelerometer, and the automatic time that this accelerometer can be configured to start on the medical treatment device when reaching the predetermined threshold levels of acceleration obtains agreement.In the scope of disclosure file, can use other parameters to obtain agreement with the automatic time that triggers on this medical treatment device in conjunction with medical treatment device, making does not need the user to interfere, point out or start, and this medical treatment device just is configured to automatic start-up time and date and time information obtains routine.In addition, in other medical treatment devices (such as injection pump, continuous blood sugar monitor, heart rate monitors etc.) of functional daily record association in time that is combined in the medical data (such as blood sugar level, insulin charge velocity, heart signal grade etc.) that is configured to safeguard patient or user that automatic time and date and time information can be obtained.
Fig. 9 A-9C shows the embodiment to the automatic expired measuring ability of blood glucose meter test strip according to an embodiment of disclosure file.At present, the test strip of using for blood glucose meter is sold or can be obtained in container, and this container has comprised the expiration date information of the test strip of wherein holding.For the diabetics that utilizes blood glucose meter or health care providers, importantly will be before the test blood sugar level outdated information of checkout bar, make that the result who obtains is accurately.
With reference to Fig. 9 A-9C, in one embodiment, test strip can be configured to have predefined parameter and detect with the automatic expiration date that allows test strip.In one aspect, provide resistance value in test strip, make that when test strip is inserted into the bar port of blood glucose meter this blood glucose meter is configured to detected resistance value and the resistance value of storing are compared, and determines whether the test strip of inserting is out of date.More specifically, in one embodiment, utilize the resistance value on the test strip, can encode to expiration date information, and this instrument can be configured to detect the resistance value of test strip and determine whether test strip is out of date.
In one aspect, can control resistance value on the test strip with the ink set design on the wake-up bars that provides on the test strip (wake up bar) and/or the pattern.Can utilize silver, gold, carbon or arbitrarily other conductor materials that are fit to increase impedance according to expectation.Blood glucose meter can be configured to the bar port and comprise control line and current connector, and control line and current connector can be configured to measure the predetermined of resistance value coded on the test strip.More specifically, in one embodiment, utilize the resistance value on the wake-up bars in the following logic sequence that expiration date is encoded:
Resistance value
Expiration date
300-310 kilo-ohm of odd number year Q1
315-320 kilo-ohm of odd number year Q2
……
350-360 kilo-ohm of even number year Q1
With reference to Fig. 9 A-9C, wave-like line can increase to change the impedance on the test strip to some extent on thickness or length as can be seen.In addition, the liner on the test strip is shown as with wake-up bars on the test port and contacts.By the mode of example, Fig. 9 A shows 300 kilo-ohms track width, and Fig. 9 B shows 315 kilo-ohms track width, and 9C shows 350 kilo-ohms track width, and each was associated with above-mentioned predetermined expiration date.
In this mode, in an embodiment of disclosure file, can detect the expiration date of test strip automatically, make test strip be used to test the expiration date that user before the blood sugar level can notified this given test strip.And although describe this automatic expired detection in conjunction with test strip and blood glucose meter, in the scope of disclosure file, other medical treatment devices or consumable project with expiration date all can be benefited from this technology described herein.
Correspondingly, the method in the aspect of disclosure file comprises: detect the predefined parameter be associated with the operating conditions of medical treatment device, such as (for example) but be not limited to blood glucose meter, analyte monitoring device (such as continuous blood sugar monitor) or injection pump; Detect the request that transmits temporal information in response to predefined parameter; And in response to the request that transmits receiving time information.
This method in aspect can comprise: store received temporal information.
Further, this method can comprise: upgrade one or more data of storing based on received temporal information.
In aspect another, this aspect can comprise: one or more data of storing that retrieval is associated with the time related information of storing, and upgrade received one or more data of storing based on received temporal information, and further, the one or more data of storing that retrieve behind the storage update.
The analyte level data that the one or more data of storing that retrieve can comprise is blood sugar measured, monitor, calibration timetable data or analyte sensor insert one or more in the time data (insertion time data).
In addition, can detect to automatically perform transmission to the request of temporal information in response to predefined parameter.
In a further aspect, this method can comprise the temporal information that demonstration is received.
This method can also comprise that reception is to the affirmation of received temporal information.
This temporal information can comprise one or more in the information of the time in one day and date and time information or other times and/or the geographical information (such as time-zone information, location message, GMT data etc.).
Medical treatment device on the other hand according to disclosure file can comprise: one or more processing units, and the memorizer that is used for the such instruction of storage, when being carried out these instructions by one or more processing units, make one or more processing units detect the predefined parameter that is associated with the operating conditions of this medical treatment device, transmitting the request to temporal information in response to this predefined parameter detects, and in response to the request that transmits receiving time information.
The memorizer that is used for the such instruction of storage can make the received temporal information of one or more processing unit storages when being carried out these instructions by one or more processing units.
The memorizer that is used for the such instruction of storage can make one or more processing units upgrade one or more data of storing based on received temporal information when being carried out these instructions by one or more processing units.
The memorizer that is used for the such instruction of storage, when being carried out these instructions by one or more processing units, can make one or more processing units retrieve the one or more data of storing that are associated with the time related information of storing, and upgrade the one or more data of storing that retrieve based on received temporal information.
In addition, be used for the memorizer of the such instruction of storage, when the one or more data of being carried out by one or more processing units after can making one or more processing unit storage updates when these instruct of storing that retrieve.
In one embodiment, medical treatment device can comprise the analyte monitoring device, such as blood glucose meter, continuous blood sugar monitor, integrated continuous blood sugar monitor and blood glucose meter or with blood glucose meter, continuous blood sugar monitor or integrated continuous blood sugar monitor and the one or more controller units that communicate in the blood glucose meter.
For example, in one aspect in, this medical treatment device can comprise external blood glucose meter.Replacedly, this medical treatment device can comprise acceptor unit or the controller unit in the continuous blood sugar monitoring system 110 (Fig. 1), its can be additionally in conjunction with the test strip port with for the treatment of the corresponding electronic circuit from the blood sample of testing in vitro bar.
In a further aspect, this medical treatment device can comprise the injection device for infused drug (such as insulin), for example, and outside injection pump, implantable injection pump, inhaled drugs allocation units or medicament injection apparatus.
The analyte level data that the one or more data of storing that retrieve comprise is blood sugar measured, monitor, calibration timetable data or analyte sensor insert time data or with any other data of time correlation connection (such as, for example such as the drug delivery timetable of the basis of the programming in injection pump profile) in one or more.
In addition, be used for the memorizer of the such instruction of storage, when being carried out these instructions by one or more processing units, can make the automatic request that transmits temporal information in response to predefined parameter detects of one or more processing units.
This device can comprise display unit, and this display unit is operably connected to one or more processing units, to show received temporal information.
The memorizer that is used for the such instruction of storage when being carried out these instructions by one or more processing units, can make one or more processing units receptions to the affirmation of received temporal information.
One or more processing units can comprise communication unit, communication unit is configured to transmit to the request of temporal information or in response to the request that transmits and comes receiving time information, or has not only transmitted to the request of temporal information but also in response to the request that transmits and come receiving time information.
Communication unit can be configured to utilize one or more the transmission or reception information in Bluetooth communication protocol, RF communication protocol, infrared communication protocol, Zigbee communication protocol, 802.1x communication protocol or the wireless personal local area network agreement.
Medical treatment device in another embodiment can comprise: for detection of the device of the predefined parameter that is associated with the operating conditions of medical treatment device, for the device that detects to transmit in response to predefined parameter to the request of temporal information, and the device that is used for coming in response to the request that transmits receiving time information.
Treatment management system among the embodiment of disclosure file comprises injection device, this injection device comprises: the processing unit that is configured to carry out date processing, and the user interface elements that is operably connected to processing unit, wherein processing unit is configured to detect the location message that is associated with injection device and is used for exporting to user interface elements.
In one embodiment, location message is based on the time.
In one aspect, location message is associated with on-site local time information based on injection device, wherein, can receive location message from global positioning system (GPS) or from receiving other devices from the information of global positioning system (personal digital assistant that enables such as mobile phone, GPS).
In one aspect, clock unit can be operatively attached to processing unit, and wherein, clock unit is configured to dynamically adjust location message based on the location of injection device.
In a further embodiment, clock unit can comprise atomic clock.
This processing unit can be configured to generate the notice that is associated with detected location message and be used for outputing to user interface elements, wherein, this notice can be used as one or more in the date and time information that is associated with the location of injection device and the temporal information and is output to user interface elements.
Processing unit can be configured to receive the one or more programming steps that join with time correlation, and wherein, one or more programming steps can comprise one or more basic profiles, programme and inject definite timetable, time-based situation alarm.
One or more in the time-based prompting that time-based situation alarm can comprise with the operation of injection device is associated.In addition, time-based situation alarm can comprise one or more in the time-based prompting that is associated with injection device user's situation.
Further, processing unit can be configured to based on detected location message and the automatic one or more time-based function that is associated with the operation of injection device of adjusting.
Method according to another embodiment comprises: detect the change on the location message for the treatment of management devices; Detected change is compared with the location message of storing; And carry out the one or more processing that are associated with the operation for the treatment of management devices based on detected change.
Change on the detected location message can comprise one or more or its combination in time zone change, time standard change, the date change.
One or more processing can comprise and generate the notice that is associated with change on the detected location message.
In addition, one or more processing can comprise: the time-based function of one or more programmings of notice treatment management devices, and its can comprise that the time-based fluid of time-based fluid delivery confirmation, the programming of time-based alarm, the programming of the programming of treat management devices transmits profile or the time-based operating conditions of programming in one or more.
In aspect another, the treatment management devices can comprise one or more in injection device or the analyte monitoring unit.
Comprise injection device and be operably connected to the communication unit of injection device by radio data network according to the treatment management system of the another embodiment of disclosure file, communication unit is configured to send synchronous request to injection device, wherein, injection device can be configured to send one or more data to communication unit in response to received synchronization request.
Radio data network can be based in Bluetooth communication protocol, RF communication protocol, infrared communication protocol, Zigbee communication protocol, 802.1x communication protocol or wireless personal local area network (such as the ANT) agreement one or more.
Further, radio data network can comprise one or more in WLAN or the WiFi network.
Communication unit can be configured to periodically transmit with predetermined time interval synchronization request.
Further, injection device can be configured to the received synchronization request of checking before sending one or more data to communication unit.
The one or more data that send communication unit to can be encrypted, and in addition, communication unit can be configured to received one or more enciphered datas are decrypted.
The one or more data that transmit can comprise the one or more information that are associated with the injection device user profiles of storing, operating parameter or the injection transmission information of injection device.
Communication unit can comprise one or more in analyte monitoring unit, personal digital assistant, mobile phone, terminal, server terminal or the extra injection device.
The system that communicates with injection device among the another embodiment of disclosure file comprises: voice-enabled device, and be configured to the injection device that utilizes one or more voice signals and this voice-enabled device to communicate.
In one aspect, this voice-enabled device can comprise one or more in telephone device, mobile phone, IP (Internet protocol) voice call, voice-enabled accountant or the voice-enabled terminal.
This injection device can be configured to start voice-enabled communication to voice-enabled device.For example, injection device can be integrated the mobile phone parts.
In one aspect, this voice-enabled communication can comprise call.
This injection device can be configured to receive the one or more voice commands from this voice-enabled device, and injection device can be configured to handle one or more voice commands to carry out one or more functions associated of injection device operation.
One or more functions associated comprise bolus dose affirmation, programmable notice or interim basal dose affirmation.
Method according to another embodiment of disclosure file comprises: start communication based on voice signal from injection device; And the voice signal that is associated with the operation of injection device of transmission.
This method can also comprise: by the request of communication network reception based on voice signal; And carry out the one or more functions that are associated with the operation of injection device based on the received request based on voice signal.
Communication based on voice signal can comprise call.
Treatment management kit according to another embodiment includes device, this injection device comprises: the processing unit that is configured to carry out date processing, and the user interface elements that is operably connected to processing unit, wherein, processing unit is configured to detect the location message that is associated with injection device and is used for outputing to user interface elements.
This equipment may further include the clock unit that is operably connected to processing unit, and wherein, clock unit is configured to dynamically adjust location message based on the location of injection device.
Clock unit can comprise atomic clock.
Further, this equipment can also comprise voice-enabled device, and wherein, this injection device can further be configured to utilize one or more voice signals and communicate with voice-enabled device.
In one aspect, voice-enabled device can comprise one or more in telephone device, mobile phone, IP (Internet protocol) voice call, voice-enabled accountant or the voice-enabled terminal.
Above-mentioned various processing (comprise the performed processing of any other suitable or similar processing units that realizes by in the processor 210 in the software application execution environment in the fluid transfer apparatus 120 and analyte monitoring system 120 and the remote terminal 140, comprise processing and the routine described in conjunction with Fig. 3-8), can be implemented as the computer program that utilizes the goal orientation language development, this language allows to come that with modular object complication system is carried out modeling and represents the abstract of real world, physical object and mutual relation thereof with establishment.Carrying out the required software (it can be stored in the memory element 240 of processor 210 (or the similar storage device in analyte monitoring system 110 or the remote terminal 140)) of inventive step can be developed and can be comprised one or more computer programs by those of ordinary skills.
In addition, except the background technology and summary of the invention of invention part, all references that this paper quotes also all are attached in the detailed description of preferred embodiment as the alternative embodiment and the part that disclose in this mode by reference.
To those skilled in the art, various other in method of operating of the present invention and the structure change and alternative all is apparent, and can not deviate from scope and spirit of the present invention.Although describe the present invention in conjunction with certain preferred embodiment, should be understood that the present invention who claims should not be restricted to these specific embodiments inadequately.Be intended to, following claims limit the scope of disclosure file, and structure and method in the scope of these claim and equivalent thereof should be covered by this scope.
Claims (29)
1. one kind is used for the method that data are obtained and/or detected, and comprising:
Detect the predefined parameter that is associated with the operating conditions of medical treatment device;
From a plurality of communication channels, determine the availability of at least one communication channel;
Detect in response to predefined parameter, transmit request to temporal information by available communication channel from described medical treatment device;
At described medical treatment device place, come receiving time information in response to the request that transmits; And
Upgrade described medical treatment device based on the temporal information that receives.
2. method according to claim 1 comprises: store received temporal information.
3. method according to claim 1 wherein, is upgraded described medical treatment device and is comprised: upgrades one or more data of storing based on received temporal information.
4. method according to claim 1, wherein, upgrade described medical treatment device and comprise:
One or more data of storing that retrieval is associated with the time related information of storing; And
Upgrade the one or more data of storing that retrieve based on received temporal information.
5. method according to claim 4 comprises: the one or more data of storing that retrieve that storage is upgraded.
6. method according to claim 4, wherein, the analyte level data that the one or more data of storing that retrieve comprise is blood sugar measured, monitor, calibration timetable data or analyte sensor insert one or more in the time data.
7. method according to claim 1 wherein, detects to automatically perform described request to temporal information in response to described predefined parameter.
8. method according to claim 1 is included on the display of described medical treatment device and shows received temporal information.
9. method according to claim 1 comprises that reception is to the affirmation of received temporal information.
10. method according to claim 1, wherein, described temporal information comprises: one or more in the information of the time in one day and the date and time information.
11. method according to claim 1 wherein, determines that from a plurality of communication channels the availability of at least one communication channel comprises which communication channel of determining in a plurality of communication channels is positioned at the transmission scope of the communication unit of described medical treatment device.
12. one kind is used for the medical treatment device that data are obtained and/or detected, comprises:
First module is configured to detect the predefined parameter that is associated with the operating conditions of medical treatment device;
Second module is configured to from a plurality of communication channels to determine the availability of at least one communication channel;
Three module is configured to detect in response to predefined parameter, transmits request to temporal information by available communication channel from described medical treatment device;
Four module is configured to come receiving time information at described medical treatment device place in response to the request that transmits; And
The 5th module is configured to upgrade described medical treatment device based on the temporal information that receives.
13. medical treatment device according to claim 12, wherein, described four module further is configured to store received temporal information.
14. medical treatment device according to claim 12, wherein, described the 5th module further is configured to when described medical treatment device is updated, and upgrades one or more data of storing based on received temporal information.
15. medical treatment device according to claim 13, wherein, described the 5th module further is configured to when described medical treatment device is updated, retrieve the one or more data of storing that are associated with the time related information of storing, and retrieve one or more data of storing based on received temporal information.
16. medical treatment device according to claim 15, wherein, described the 5th module further is configured to the one or more data of storing that retrieve behind the storage update.
17. medical treatment device according to claim 12, wherein, described medical treatment device comprises the analyte monitoring device.
18. medical treatment device according to claim 17, wherein, described analyte monitoring device comprises one of the following: blood glucose meter, continuous blood sugar monitor, integrated continuous blood sugar monitor and blood glucose meter.
19. medical treatment device according to claim 12, wherein, described medical treatment device comprises injection device.
20. medical treatment device according to claim 19, wherein, described injection device comprises: outside injection pump, implantable injection pump, inhaled drugs allocation units or medicament injection apparatus.
21. medical treatment device according to claim 15, wherein, the analyte level data that the one or more data of storing that retrieve comprise is blood sugar measured, monitor, calibration timetable data or analyte sensor insert one or more in the time data.
22. medical treatment device according to claim 12, wherein, described three module further is configured to transmit described request to temporal information automatically in response to described predefined parameter detection.
23. medical treatment device according to claim 12 comprises the display unit that is operably connected to described the 5th module, described display unit is configured to show received temporal information.
24. medical treatment device according to claim 12 further comprises: the 6th module is configured to receive the affirmation to received temporal information.
25. medical treatment device according to claim 12, wherein, described temporal information comprises: one or more in the information of the time in one day and the date and time information.
26. medical treatment device according to claim 12, wherein, described three module be configured to transmit described to the request of temporal information or in response to the request that transmits receiving time information, perhaps be configured to transmit described to the request of temporal information and in response to the request that transmits receiving time information.
27. medical treatment device according to claim 26, wherein, described three module is configured to utilize one or more the transmission or reception information in 802.1x communication protocol or the wireless personal local area network agreement.
28. medical treatment device according to claim 17, wherein, described analyte monitoring device comprises control unit, described control unit and blood glucose meter, continuous blood sugar monitor or integrated continuous blood sugar monitor and one or more the communicating in the blood glucose meter.
29. the described medical treatment device of claim 26, wherein, described three module is configured to utilize one or more the transmission or reception information in Bluetooth communication protocol, RF communication protocol, infrared communication protocol or the Zigbee communication protocol.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89015407P | 2007-02-15 | 2007-02-15 | |
| US60/890,154 | 2007-02-15 | ||
| US12/031,664 | 2008-02-14 | ||
| US12/031,664 US8121857B2 (en) | 2007-02-15 | 2008-02-14 | Device and method for automatic data acquisition and/or detection |
| PCT/US2008/054165 WO2008101211A2 (en) | 2007-02-15 | 2008-02-15 | Device and method for automatic data acquisition and/or detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101610718A CN101610718A (en) | 2009-12-23 |
| CN101610718B true CN101610718B (en) | 2013-10-02 |
Family
ID=39690831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008800051491A Expired - Fee Related CN101610718B (en) | 2007-02-15 | 2008-02-15 | Device and method for automatic data acquisition and/or detection |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US8121857B2 (en) |
| EP (1) | EP2112905A2 (en) |
| CN (1) | CN101610718B (en) |
| BR (1) | BRPI0807499A2 (en) |
| CA (1) | CA2677716A1 (en) |
| RU (1) | RU2499555C2 (en) |
| WO (1) | WO2008101211A2 (en) |
Families Citing this family (133)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080172026A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a suspension bolus |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
| US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8956291B2 (en) * | 2005-02-22 | 2015-02-17 | Admetsys Corporation | Balanced physiological monitoring and treatment system |
| US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
| WO2008057729A2 (en) | 2006-10-16 | 2008-05-15 | Hospira, Inc. | System and method for comparing and utilizing activity information and configuration information from mulitple device management systems |
| US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
| US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
| US9026370B2 (en) | 2007-12-18 | 2015-05-05 | Hospira, Inc. | User interface improvements for medical devices |
| US20090177142A1 (en) | 2008-01-09 | 2009-07-09 | Smiths Medical Md, Inc | Insulin pump with add-on modules |
| US9550031B2 (en) | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
| CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
| JP4856777B2 (en) * | 2008-03-27 | 2012-01-18 | パナソニック株式会社 | Sample measuring apparatus, sample measuring system, and sample measuring method |
| US20090292179A1 (en) * | 2008-05-21 | 2009-11-26 | Ethicon Endo-Surgery, Inc. | Medical system having a medical unit and a display monitor |
| US20110137208A1 (en) * | 2008-07-24 | 2011-06-09 | Admetsys Corporation | Device and method for automatically sampling and measuring blood analytes |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
| EP3284494A1 (en) | 2009-07-30 | 2018-02-21 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
| DK3988470T3 (en) | 2009-08-31 | 2023-08-28 | Abbott Diabetes Care Inc | Display devices for a medical device |
| WO2011041429A1 (en) | 2009-09-29 | 2011-04-07 | Admetsys Corporation | System and method for differentiating containers in medication delivery |
| US9041730B2 (en) | 2010-02-12 | 2015-05-26 | Dexcom, Inc. | Receivers for analyzing and displaying sensor data |
| WO2011149857A1 (en) * | 2010-05-24 | 2011-12-01 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
| AU2011265005B2 (en) * | 2010-06-07 | 2015-04-09 | Amgen Inc. | Drug delivery device |
| US20120072236A1 (en) * | 2010-08-06 | 2012-03-22 | Benjamin Atkin | Insulin pen data recording and transmission device |
| US10201296B2 (en) | 2010-11-11 | 2019-02-12 | Ascensia Diabetes Care Holdings Ag | Apparatus, systems, and methods adapted to transmit analyte data having common electronic architecture |
| US20130085349A1 (en) | 2011-06-21 | 2013-04-04 | Yofimeter, Llc | Analyte testing devices |
| AU2012299169B2 (en) | 2011-08-19 | 2017-08-24 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
| ES2959510T3 (en) | 2011-10-21 | 2024-02-26 | Icu Medical Inc | Medical device update system |
| WO2013090709A1 (en) | 2011-12-16 | 2013-06-20 | Hospira, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
| CN103186516B (en) * | 2011-12-29 | 2016-07-06 | 广州市中海达测绘仪器有限公司 | A kind of generation monitors the method for chart, Apparatus and system |
| ES2741725T3 (en) | 2012-03-30 | 2020-02-12 | Icu Medical Inc | Air detection system and method to detect air in a pump of an infusion system |
| US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
| US11253661B2 (en) | 2012-06-25 | 2022-02-22 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and patient interaction |
| EP2879733B1 (en) | 2012-07-31 | 2019-06-05 | ICU Medical, Inc. | Patient care system for critical medications |
| US9801541B2 (en) | 2012-12-31 | 2017-10-31 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| US9730621B2 (en) | 2012-12-31 | 2017-08-15 | Dexcom, Inc. | Remote monitoring of analyte measurements |
| WO2014138446A1 (en) | 2013-03-06 | 2014-09-12 | Hospira,Inc. | Medical device communication method |
| US9931036B2 (en) | 2013-03-14 | 2018-04-03 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
| US9445445B2 (en) | 2013-03-14 | 2016-09-13 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
| US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
| US9486171B2 (en) | 2013-03-15 | 2016-11-08 | Tandem Diabetes Care, Inc. | Predictive calibration |
| US9492608B2 (en) | 2013-03-15 | 2016-11-15 | Tandem Diabetes Care, Inc. | Method and device utilizing insulin delivery protocols |
| AU2014268355B2 (en) | 2013-05-24 | 2018-06-14 | Icu Medical, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
| ES2838450T3 (en) | 2013-05-29 | 2021-07-02 | Icu Medical Inc | Infusion set that uses one or more sensors and additional information to make an air determination relative to the infusion set |
| ES2845748T3 (en) | 2013-05-29 | 2021-07-27 | Icu Medical Inc | Infusion system and method of use that prevent oversaturation of an analog-digital converter |
| US9867953B2 (en) | 2013-06-21 | 2018-01-16 | Tandem Diabetes Care, Inc. | System and method for infusion set dislodgement detection |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| ES2716907T3 (en) | 2013-08-28 | 2019-06-17 | Gecko Health Innovations Inc | Devices to monitor compliance and devices to monitor the use of consumable dispensers |
| CA2922425C (en) | 2013-08-30 | 2023-05-16 | Hospira, Inc. | System and method of monitoring and managing a remote infusion regimen |
| US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
| WO2015047870A1 (en) | 2013-09-26 | 2015-04-02 | Companion Medical, Inc. | System for administering a medicament |
| US9974469B2 (en) * | 2013-11-07 | 2018-05-22 | Dexcom, Inc. | Systems and methods for a continuous monitoring of analyte values |
| US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
| AU2014353130B9 (en) | 2013-11-19 | 2019-09-05 | Icu Medical, Inc. | Infusion pump automation system and method |
| US10569015B2 (en) | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| CN103705247A (en) * | 2013-12-09 | 2014-04-09 | 杨荣 | Blood glucose meter with blood glucose change recording function |
| WO2015100340A1 (en) | 2013-12-26 | 2015-07-02 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
| JP6641282B2 (en) * | 2014-01-10 | 2020-02-05 | アセンシア・ディアベティス・ケア・ホールディングス・アーゲー | Setup synchronization apparatus and method for end-user medical device |
| CA2938092A1 (en) | 2014-02-11 | 2015-08-20 | Smiths Medical Asd, Inc. | Pump startup algorithms and related systems and methods |
| CA2939302C (en) | 2014-02-28 | 2021-12-28 | Hospira, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
| TWI686177B (en) | 2014-04-11 | 2020-03-01 | 瑞士商安晟信醫療科技控股公司 | Wireless transmitter adapters for battery-operated biosensor meters and methods of providing same |
| EP3138032A4 (en) | 2014-04-30 | 2017-12-20 | ICU Medical, Inc. | Patient care system with conditional alarm forwarding |
| AU2015266706B2 (en) | 2014-05-29 | 2020-01-30 | Icu Medical, Inc. | Infusion system and pump with configurable closed loop delivery rate catch-up |
| US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
| CN107079061A (en) | 2014-07-07 | 2017-08-18 | 安晟信医疗科技控股公司 | For the method and apparatus for improving device pairing using double duty piezo-electric acoustical component and vibrating sensor |
| WO2016007935A2 (en) | 2014-07-10 | 2016-01-14 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
| US10617357B2 (en) * | 2014-08-24 | 2020-04-14 | Halo Wearables, Llc | Swappable wearable device |
| US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
| US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
| US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
| US11361863B2 (en) | 2015-04-29 | 2022-06-14 | Ascensia Diabetes Care Holdings Ag | Location-based wireless diabetes management systems, methods and apparatus |
| US9878097B2 (en) | 2015-04-29 | 2018-01-30 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
| WO2016189417A1 (en) | 2015-05-26 | 2016-12-01 | Hospira, Inc. | Infusion pump system and method with multiple drug library editor source capability |
| US10255412B2 (en) | 2015-11-13 | 2019-04-09 | Reciprocal Labs Corporation | Real time adaptive controller medication dosing |
| WO2017091736A1 (en) * | 2015-11-23 | 2017-06-01 | Mayo Foundation For Medical Education And Research | Processing physiological electrical data for analyte assessments |
| AU2016380858B2 (en) | 2015-12-28 | 2019-08-08 | Dexcom, Inc. | Systems and methods for remote and host monitoring communications |
| US10449294B1 (en) | 2016-01-05 | 2019-10-22 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
| AU2016385454B2 (en) | 2016-01-05 | 2021-12-16 | Bigfoot Biomedical, Inc. | Operating multi-modal medicine delivery systems |
| WO2017132577A1 (en) | 2016-01-29 | 2017-08-03 | Companion Medical, Inc. | Automatic medication delivery tracking |
| US10541987B2 (en) | 2016-02-26 | 2020-01-21 | Tandem Diabetes Care, Inc. | Web browser-based device communication workflow |
| ES2837390T3 (en) | 2016-03-31 | 2021-06-30 | Dexcom Inc | Analyte monitoring system |
| EP4085944A1 (en) | 2016-05-13 | 2022-11-09 | ICU Medical, Inc. | Infusion pump system with common line auto flush |
| GB2550854B (en) | 2016-05-25 | 2019-06-26 | Ge Aviat Systems Ltd | Aircraft time synchronization system |
| AU2017277804B2 (en) | 2016-06-10 | 2022-05-26 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
| US11574737B2 (en) | 2016-07-14 | 2023-02-07 | Icu Medical, Inc. | Multi-communication path selection and security system for a medical device |
| CN109789264B (en) | 2016-09-27 | 2021-06-22 | 比格福特生物医药公司 | Drug injection and disease management systems, devices and methods |
| CN109922716A (en) * | 2016-12-12 | 2019-06-21 | 比格福特生物医药公司 | The alarm of medicament delivery device and vigilant and relevant system and method |
| EP3634528B1 (en) | 2017-06-07 | 2023-06-07 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
| US11484657B2 (en) | 2017-06-09 | 2022-11-01 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods |
| CA3065746A1 (en) | 2017-08-18 | 2019-02-21 | Abbott Diabetes Care Inc. | Systems, devices, and methods related to the individualized calibration and/or manufacturing of medical devices |
| WO2019075352A1 (en) | 2017-10-12 | 2019-04-18 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose recommendation and management |
| EP3710076B1 (en) | 2017-11-13 | 2023-12-27 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
| US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
| US10987464B2 (en) | 2017-12-12 | 2021-04-27 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
| EP3724891A1 (en) | 2017-12-12 | 2020-10-21 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
| US11077243B2 (en) | 2017-12-12 | 2021-08-03 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
| US11083852B2 (en) | 2017-12-12 | 2021-08-10 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
| US11116899B2 (en) | 2017-12-12 | 2021-09-14 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
| US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
| US11089980B1 (en) * | 2018-01-17 | 2021-08-17 | Verily Life Sciences Llc | Investigation of glycemic events in blood glucose data |
| US10624591B1 (en) | 2018-02-07 | 2020-04-21 | Verily Life Sciences Llc | Annotations of continuous glucose monitoring data |
| US11475988B1 (en) | 2018-01-17 | 2022-10-18 | Verily Ufe Sciences LLC | Imputation of blood glucose monitoring data |
| EP3746149A4 (en) | 2018-02-01 | 2021-10-27 | Shifamed Holdings, LLC | Intravascular blood pumps and methods of use and manufacture |
| US11804303B2 (en) | 2018-03-01 | 2023-10-31 | Reciprocal Labs Corporation | Evaluation of respiratory disease risk in a geographic region based on medicament device monitoring |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| WO2019200281A1 (en) | 2018-04-12 | 2019-10-17 | DiaTech Diabetic Technologies, LLC | Systems and methods for detecting disruptions in fluid delivery devices |
| US10898653B2 (en) | 2018-05-08 | 2021-01-26 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
| US11664107B2 (en) | 2018-05-08 | 2023-05-30 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods using a prescription-regulated software application |
| USD893020S1 (en) | 2018-05-11 | 2020-08-11 | Companion Medical, Inc. | Injection pen |
| USD892819S1 (en) | 2018-06-20 | 2020-08-11 | Companion Medical, Inc. | Display screen with graphical user interface |
| US11587663B2 (en) | 2018-06-20 | 2023-02-21 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for medicine dose calculation and reporting |
| NZ793485A (en) | 2018-07-17 | 2023-06-30 | Icu Medical Inc | Systems and methods for facilitating clinical messaging in a network environment |
| EP3824386B1 (en) | 2018-07-17 | 2024-02-21 | ICU Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
| US11152109B2 (en) | 2018-07-17 | 2021-10-19 | Icu Medical, Inc. | Detecting missing messages from clinical environment |
| US10861592B2 (en) | 2018-07-17 | 2020-12-08 | Icu Medical, Inc. | Reducing infusion pump network congestion by staggering updates |
| AU2019309766A1 (en) | 2018-07-26 | 2021-03-18 | Icu Medical, Inc. | Drug library management system |
| US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
| US10736037B2 (en) | 2018-12-26 | 2020-08-04 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
| US11464908B2 (en) | 2019-02-18 | 2022-10-11 | Tandem Diabetes Care, Inc. | Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps |
| EP3927391A4 (en) | 2019-02-19 | 2022-11-16 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
| EP3946514A4 (en) | 2019-03-26 | 2022-12-21 | Tandem Diabetes Care, Inc. | Method of pairing an infusion pump with a remote control device |
| US11948671B2 (en) | 2019-04-11 | 2024-04-02 | Medtronic Minimed, Inc. | Intelligent accessories for medicine dispensing device |
| US11166670B1 (en) | 2019-04-30 | 2021-11-09 | Verily Life Sciences Llc | Managing meal excursions in blood glucose data |
| US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
| WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
| US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
| WO2022020184A1 (en) | 2020-07-21 | 2022-01-27 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
| US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
| US11701473B2 (en) | 2021-06-23 | 2023-07-18 | Medtronic Minimed, Inc. | Reusable injection pens |
| WO2023154059A1 (en) * | 2022-02-14 | 2023-08-17 | Click Therapeutics, Inc. | Estimation of event generation times to synchronize recordation data |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019974A (en) * | 1987-05-01 | 1991-05-28 | Diva Medical Systems Bv | Diabetes management system and apparatus |
| US5673322A (en) * | 1996-03-22 | 1997-09-30 | Bell Communications Research, Inc. | System and method for providing protocol translation and filtering to access the world wide web from wireless or low-bandwidth networks |
| US6144922A (en) * | 1997-10-31 | 2000-11-07 | Mercury Diagnostics, Incorporated | Analyte concentration information collection and communication system |
| US6925393B1 (en) * | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
Family Cites Families (371)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1191363A (en) | 1968-02-19 | 1970-05-13 | Pavelle Ltd | Improvements in or relating to Electronic Thermostats. |
| US3949388A (en) | 1972-11-13 | 1976-04-06 | Monitron Industries, Inc. | Physiological sensor and transmitter |
| US3926760A (en) | 1973-09-28 | 1975-12-16 | Du Pont | Process for electrophoretic deposition of polymer |
| US4245634A (en) | 1975-01-22 | 1981-01-20 | Hospital For Sick Children | Artificial beta cell |
| US4036749A (en) | 1975-04-30 | 1977-07-19 | Anderson Donald R | Purification of saline water |
| US4055175A (en) | 1976-05-07 | 1977-10-25 | Miles Laboratories, Inc. | Blood glucose control apparatus |
| US4129128A (en) | 1977-02-23 | 1978-12-12 | Mcfarlane Richard H | Securing device for catheter placement assembly |
| US4344438A (en) | 1978-08-02 | 1982-08-17 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Optical sensor of plasma constituents |
| AU530979B2 (en) | 1978-12-07 | 1983-08-04 | Aus. Training Aids Pty. Ltd., | Detecting position of bullet fired at target |
| US4373527B1 (en) | 1979-04-27 | 1995-06-27 | Univ Johns Hopkins | Implantable programmable medication infusion system |
| US4425920A (en) | 1980-10-24 | 1984-01-17 | Purdue Research Foundation | Apparatus and method for measurement and control of blood pressure |
| US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4392849A (en) | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
| DE3138194A1 (en) | 1981-09-25 | 1983-04-14 | Basf Ag, 6700 Ludwigshafen | WATER-INSOLUBLE POROESES PROTEIN MATERIAL, THEIR PRODUCTION AND USE |
| US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
| FI831399L (en) | 1982-04-29 | 1983-10-30 | Agripat Sa | KONTAKTLINS AV HAERDAD POLYVINYL ALCOHOL |
| US4509531A (en) | 1982-07-28 | 1985-04-09 | Teledyne Industries, Inc. | Personal physiological monitor |
| US4527240A (en) | 1982-12-29 | 1985-07-02 | Kvitash Vadim I | Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems |
| US5509410A (en) | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
| CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
| US4538616A (en) | 1983-07-25 | 1985-09-03 | Robert Rogoff | Blood sugar level sensing and monitoring transducer |
| DE3429596A1 (en) | 1984-08-10 | 1986-02-20 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR THE PHYSIOLOGICAL FREQUENCY CONTROL OF A PACEMAKER PROVIDED WITH A PICTURE ELECTRODE |
| CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
| US5279294A (en) | 1985-04-08 | 1994-01-18 | Cascade Medical, Inc. | Medical diagnostic system |
| US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
| US4890620A (en) | 1985-09-20 | 1990-01-02 | The Regents Of The University Of California | Two-dimensional diffusion glucose substrate sensing electrode |
| US4757022A (en) | 1986-04-15 | 1988-07-12 | Markwell Medical Institute, Inc. | Biological fluid measuring device |
| US4703756A (en) | 1986-05-06 | 1987-11-03 | The Regents Of The University Of California | Complete glucose monitoring system with an implantable, telemetered sensor module |
| US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
| US5055171A (en) | 1986-10-06 | 1991-10-08 | T And G Corporation | Ionic semiconductor materials and applications thereof |
| US4777953A (en) | 1987-02-25 | 1988-10-18 | Ash Medical Systems, Inc. | Capillary filtration and collection method for long-term monitoring of blood constituents |
| US5002054A (en) | 1987-02-25 | 1991-03-26 | Ash Medical Systems, Inc. | Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body |
| US4854322A (en) | 1987-02-25 | 1989-08-08 | Ash Medical Systems, Inc. | Capillary filtration and collection device for long-term monitoring of blood constituents |
| US4759828A (en) | 1987-04-09 | 1988-07-26 | Nova Biomedical Corporation | Glucose electrode and method of determining glucose |
| US4749985A (en) | 1987-04-13 | 1988-06-07 | United States Of America As Represented By The United States Department Of Energy | Functional relationship-based alarm processing |
| GB8725936D0 (en) | 1987-11-05 | 1987-12-09 | Genetics Int Inc | Sensing system |
| US4925268A (en) | 1988-07-25 | 1990-05-15 | Abbott Laboratories | Fiber-optic physiological probes |
| EP0353328A1 (en) | 1988-08-03 | 1990-02-07 | Dräger Nederland B.V. | A polarographic-amperometric three-electrode sensor |
| US5340722A (en) | 1988-08-24 | 1994-08-23 | Avl Medical Instruments Ag | Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method |
| US5108889A (en) | 1988-10-12 | 1992-04-28 | Thorne, Smith, Astill Technologies, Inc. | Assay for determining analyte using mercury release followed by detection via interaction with aluminum |
| US5360404A (en) | 1988-12-14 | 1994-11-01 | Inviro Medical Devices Ltd. | Needle guard and needle assembly for syringe |
| US5068536A (en) | 1989-01-19 | 1991-11-26 | Futrex, Inc. | Method for providing custom calibration for near infrared instruments for measurement of blood glucose |
| DK0385805T3 (en) | 1989-03-03 | 1996-09-23 | Edward W Stark | Method and apparatus for signal processing |
| JPH02298855A (en) | 1989-03-20 | 1990-12-11 | Assoc Univ Inc | Electrochemical biosensor using immobilized enzyme and redox polymer |
| US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
| EP0396788A1 (en) | 1989-05-08 | 1990-11-14 | Dräger Nederland B.V. | Process and sensor for measuring the glucose content of glucosecontaining fluids |
| FR2648353B1 (en) | 1989-06-16 | 1992-03-27 | Europhor Sa | MICRODIALYSIS PROBE |
| US5431160A (en) | 1989-07-19 | 1995-07-11 | University Of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
| US4986271A (en) | 1989-07-19 | 1991-01-22 | The University Of New Mexico | Vivo refillable glucose sensor |
| US5320725A (en) | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
| US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
| US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
| US5264105A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
| US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
| US5082550A (en) | 1989-12-11 | 1992-01-21 | The United States Of America As Represented By The Department Of Energy | Enzyme electrochemical sensor electrode and method of making it |
| US5342789A (en) | 1989-12-14 | 1994-08-30 | Sensor Technologies, Inc. | Method and device for detecting and quantifying glucose in body fluids |
| US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
| JP2701977B2 (en) | 1990-09-28 | 1998-01-21 | ファイザー インク | Dosage form containing hydrophobic medium |
| DE69126885T3 (en) | 1990-12-12 | 2001-10-18 | Sherwood Serv Ag | CALIBRATION OF AN INFRARED THERMOMETER BY MEANS OF AREA CALIBRATION DISPLAY |
| CA2050057A1 (en) | 1991-03-04 | 1992-09-05 | Adam Heller | Interferant eliminating biosensors |
| US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| US5262305A (en) | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
| US5469855A (en) | 1991-03-08 | 1995-11-28 | Exergen Corporation | Continuous temperature monitor |
| US5122925A (en) | 1991-04-22 | 1992-06-16 | Control Products, Inc. | Package for electronic components |
| GB9120144D0 (en) | 1991-09-20 | 1991-11-06 | Imperial College | A dialysis electrode device |
| US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| US5372427A (en) | 1991-12-19 | 1994-12-13 | Texas Instruments Incorporated | Temperature sensor |
| US5285792A (en) | 1992-01-10 | 1994-02-15 | Physio-Control Corporation | System for producing prioritized alarm messages in a medical instrument |
| US5246867A (en) | 1992-01-17 | 1993-09-21 | University Of Maryland At Baltimore | Determination and quantification of saccharides by luminescence lifetimes and energy transfer |
| IL104365A0 (en) | 1992-01-31 | 1993-05-13 | Gensia Pharma | Method and apparatus for closed loop drug delivery |
| US5328927A (en) | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| US5711001A (en) | 1992-05-08 | 1998-01-20 | Motorola, Inc. | Method and circuit for acquisition by a radio receiver |
| GB9211402D0 (en) | 1992-05-29 | 1992-07-15 | Univ Manchester | Sensor devices |
| DK95792A (en) | 1992-07-24 | 1994-01-25 | Radiometer As | Sensor for non-invasive, in vivo determination of an analyte and blood flow |
| WO1994010553A1 (en) | 1992-10-23 | 1994-05-11 | Optex Biomedical, Inc. | Fibre-optic probe for the measurement of fluid parameters |
| US5899855A (en) | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
| US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
| ZA938555B (en) | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
| US5299571A (en) | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
| DK0622119T3 (en) | 1993-04-23 | 2000-04-10 | Roche Diagnostics Gmbh | Test element storage system |
| DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
| US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
| US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
| US5791344A (en) | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
| US5536249A (en) | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
| US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
| US5609575A (en) | 1994-04-11 | 1997-03-11 | Graseby Medical Limited | Infusion pump and method with dose-rate calculation |
| US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
| DE4415896A1 (en) | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysis system for monitoring the concentration of an analyte in the blood of a patient |
| US6213972B1 (en) | 1994-09-13 | 2001-04-10 | Alaris Medical Systems, Inc. | Fluid flow resistance monitoring system |
| US5568806A (en) | 1995-02-16 | 1996-10-29 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
| US5628310A (en) | 1995-05-19 | 1997-05-13 | Joseph R. Lakowicz | Method and apparatus to perform trans-cutaneous analyte monitoring |
| US5995860A (en) | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
| US5665222A (en) | 1995-10-11 | 1997-09-09 | E. Heller & Company | Soybean peroxidase electrochemical sensor |
| US5711861A (en) | 1995-11-22 | 1998-01-27 | Ward; W. Kenneth | Device for monitoring changes in analyte concentration |
| FI960636A (en) | 1996-02-12 | 1997-08-13 | Nokia Mobile Phones Ltd | A procedure for monitoring the health of a patient |
| DE19618597B4 (en) | 1996-05-09 | 2005-07-21 | Institut für Diabetestechnologie Gemeinnützige Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm | Method for determining the concentration of tissue glucose |
| EP0914178B1 (en) | 1996-06-18 | 2003-03-12 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
| EP0923335B1 (en) | 1996-07-08 | 2006-08-23 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
| US6544193B2 (en) | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
| US5714123A (en) * | 1996-09-30 | 1998-02-03 | Lifescan, Inc. | Protective shield for a blood glucose strip |
| US6032064A (en) | 1996-10-11 | 2000-02-29 | Aspect Medical Systems, Inc. | Electrode array system for measuring electrophysiological signals |
| US6027459A (en) | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
| US5964993A (en) | 1996-12-19 | 1999-10-12 | Implanted Biosystems Inc. | Glucose sensor |
| US6122351A (en) | 1997-01-21 | 2000-09-19 | Med Graph, Inc. | Method and system aiding medical diagnosis and treatment |
| US6607509B2 (en) | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
| US6093172A (en) | 1997-02-05 | 2000-07-25 | Minimed Inc. | Injector for a subcutaneous insertion set |
| JP3394262B2 (en) | 1997-02-06 | 2003-04-07 | セラセンス、インク． | Small volume in vitro analyte sensor |
| EP1011426A1 (en) | 1997-02-26 | 2000-06-28 | Diasense, Inc. | Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose |
| US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
| US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
| US6558321B1 (en) | 1997-03-04 | 2003-05-06 | Dexcom, Inc. | Systems and methods for remote monitoring and modulation of medical devices |
| US6741877B1 (en) | 1997-03-04 | 2004-05-25 | Dexcom, Inc. | Device and method for determining analyte levels |
| US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
| US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
| US5942979A (en) | 1997-04-07 | 1999-08-24 | Luppino; Richard | On guard vehicle safety warning system |
| US5935224A (en) | 1997-04-24 | 1999-08-10 | Microsoft Corporation | Method and apparatus for adaptively coupling an external peripheral device to either a universal serial bus port on a computer or hub or a game port on a computer |
| US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
| US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
| US7267665B2 (en) | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
| CA2294610A1 (en) | 1997-06-16 | 1998-12-23 | George Moshe Katz | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
| US6117290A (en) | 1997-09-26 | 2000-09-12 | Pepex Biomedical, Llc | System and method for measuring a bioanalyte such as lactate |
| US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
| US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
| FI107080B (en) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | measuring device |
| ES2281143T3 (en) | 1997-11-12 | 2007-09-16 | Lightouch Medical, Inc. | METHOD FOR THE NON-INVASIVE MEASUREMENT OF AN ANALYTE. |
| US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
| CA2575064C (en) | 1997-12-31 | 2010-02-02 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
| US6024699A (en) | 1998-03-13 | 2000-02-15 | Healthware Corporation | Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients |
| JPH11296598A (en) | 1998-04-07 | 1999-10-29 | Seizaburo Arita | System and method for predicting blood-sugar level and record medium where same method is recorded |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| JP2002514452A (en) | 1998-05-13 | 2002-05-21 | シグナス， インコーポレイテッド | Signal processing for measurement of physiological analytes |
| US6121611A (en) | 1998-05-20 | 2000-09-19 | Molecular Imaging Corporation | Force sensing probe for scanning probe microscopy |
| US6248067B1 (en) | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
| US6740518B1 (en) | 1998-09-17 | 2004-05-25 | Clinical Micro Sensors, Inc. | Signal detection techniques for the detection of analytes |
| JP3537136B2 (en) | 1998-09-30 | 2004-06-14 | シグナス， インコーポレイテッド | Method and apparatus for predicting physiological values |
| US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| DK1413245T3 (en) | 1998-10-08 | 2011-10-10 | Medtronic Minimed Inc | Installations for monitoring a characteristic of remote sensing |
| US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| EP1131114B1 (en) | 1998-11-20 | 2004-06-16 | The University of Connecticut | Apparatus and method for control of tissue/implant interactions |
| US6377894B1 (en) * | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
| US6561978B1 (en) | 1999-02-12 | 2003-05-13 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
| US6360888B1 (en) | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
| US6424847B1 (en) | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| US6285897B1 (en) | 1999-04-07 | 2001-09-04 | Endonetics, Inc. | Remote physiological monitoring system |
| US6200265B1 (en) | 1999-04-16 | 2001-03-13 | Medtronic, Inc. | Peripheral memory patch and access method for use with an implantable medical device |
| US6669663B1 (en) | 1999-04-30 | 2003-12-30 | Medtronic, Inc. | Closed loop medicament pump |
| US7806886B2 (en) | 1999-06-03 | 2010-10-05 | Medtronic Minimed, Inc. | Apparatus and method for controlling insulin infusion with state variable feedback |
| US6423035B1 (en) | 1999-06-18 | 2002-07-23 | Animas Corporation | Infusion pump with a sealed drive mechanism and improved method of occlusion detection |
| EP2322645A1 (en) | 1999-06-18 | 2011-05-18 | Abbott Diabetes Care Inc. | Mass transport limited in vivo analyte sensor |
| US7113821B1 (en) | 1999-08-25 | 2006-09-26 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery |
| AT408182B (en) | 1999-09-17 | 2001-09-25 | Schaupp Lukas Dipl Ing Dr Tech | DEVICE FOR VIVO MEASURING SIZES IN LIVING ORGANISMS |
| EP1217942A1 (en) | 1999-09-24 | 2002-07-03 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
| US6478736B1 (en) | 1999-10-08 | 2002-11-12 | Healthetech, Inc. | Integrated calorie management system |
| US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| WO2001036660A2 (en) | 1999-11-15 | 2001-05-25 | Therasense, Inc. | Transition metal complexes attached to a polymer via a flexible chain |
| US6873268B2 (en) | 2000-01-21 | 2005-03-29 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| US7369635B2 (en) | 2000-01-21 | 2008-05-06 | Medtronic Minimed, Inc. | Rapid discrimination preambles and methods for using the same |
| US7003336B2 (en) | 2000-02-10 | 2006-02-21 | Medtronic Minimed, Inc. | Analyte sensor method of making the same |
| US7890295B2 (en) | 2000-02-23 | 2011-02-15 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
| US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
| WO2001072208A2 (en) | 2000-03-29 | 2001-10-04 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| US6610012B2 (en) | 2000-04-10 | 2003-08-26 | Healthetech, Inc. | System and method for remote pregnancy monitoring |
| US6440068B1 (en) | 2000-04-28 | 2002-08-27 | International Business Machines Corporation | Measuring user health as measured by multiple diverse health measurement devices utilizing a personal storage device |
| WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
| US7181261B2 (en) | 2000-05-15 | 2007-02-20 | Silver James H | Implantable, retrievable, thrombus minimizing sensors |
| US6442413B1 (en) | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
| US6865505B2 (en) * | 2000-06-02 | 2005-03-08 | Arkray, Inc. | Measurement assisting system and measurement assisting method |
| EP1309271B1 (en) | 2000-08-18 | 2008-04-16 | Animas Technologies LLC | Device for prediction of hypoglycemic events |
| US6633772B2 (en) | 2000-08-18 | 2003-10-14 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
| US6695860B1 (en) | 2000-11-13 | 2004-02-24 | Isense Corp. | Transcutaneous sensor insertion device |
| US7052483B2 (en) | 2000-12-19 | 2006-05-30 | Animas Corporation | Transcutaneous inserter for low-profile infusion sets |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6970529B2 (en) | 2001-01-16 | 2005-11-29 | International Business Machines Corporation | Unified digital architecture |
| US20040197846A1 (en) | 2001-01-18 | 2004-10-07 | Linda Hockersmith | Determination of glucose sensitivity and a method to manipulate blood glucose concentration |
| CN1525834A (en) | 2001-01-22 | 2004-09-01 | - | Lancet device having capillary action |
| US6968294B2 (en) | 2001-03-15 | 2005-11-22 | Koninklijke Philips Electronics N.V. | Automatic system for monitoring person requiring care and his/her caretaker |
| US6698269B2 (en) | 2001-04-27 | 2004-03-02 | Oceana Sensor Technologies, Inc. | Transducer in-situ testing apparatus and method |
| US7395214B2 (en) | 2001-05-11 | 2008-07-01 | Craig P Shillingburg | Apparatus, device and method for prescribing, administering and monitoring a treatment regimen for a patient |
| US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| US7044911B2 (en) | 2001-06-29 | 2006-05-16 | Philometron, Inc. | Gateway platform for biological monitoring and delivery of therapeutic compounds |
| US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
| US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
| US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
| US6544212B2 (en) | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
| US20030039298A1 (en) * | 2001-08-22 | 2003-02-27 | Lear Corporation | System and method of vehicle climate control |
| US6814844B2 (en) | 2001-08-29 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor with code pattern |
| US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
| US7052591B2 (en) | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
| US6830562B2 (en) | 2001-09-27 | 2004-12-14 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
| US7204823B2 (en) | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
| US7399277B2 (en) | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
| US7022072B2 (en) | 2001-12-27 | 2006-04-04 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
| US6980852B2 (en) | 2002-01-25 | 2005-12-27 | Subqiview Inc. | Film barrier dressing for intravascular tissue monitoring system |
| US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
| US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
| US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
| EP1487519B1 (en) | 2002-02-26 | 2013-06-12 | TecPharma Licensing AG | Insertion device for an insertion set and method of using the same |
| US6998247B2 (en) | 2002-03-08 | 2006-02-14 | Sensys Medical, Inc. | Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers |
| US6936006B2 (en) | 2002-03-22 | 2005-08-30 | Novo Nordisk, A/S | Atraumatic insertion of a subcutaneous device |
| US7448996B2 (en) * | 2002-04-16 | 2008-11-11 | Carematix, Inc. | Method and apparatus for remotely monitoring the condition of a patient |
| US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
| US7410468B2 (en) | 2002-04-19 | 2008-08-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| EP1498067A1 (en) | 2002-04-25 | 2005-01-19 | Matsushita Electric Industrial Co., Ltd. | Dosage determination supporting device, injector, and health management supporting system |
| US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
| US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
| US20040010207A1 (en) | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
| US7404796B2 (en) | 2004-03-01 | 2008-07-29 | Becton Dickinson And Company | System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| US7192405B2 (en) | 2002-09-30 | 2007-03-20 | Becton, Dickinson And Company | Integrated lancet and bodily fluid sensor |
| EP1575656B1 (en) | 2002-10-11 | 2009-06-17 | Becton, Dickinson and Company | Insulin delivery system with sensor |
| US20040073266A1 (en) | 2002-10-15 | 2004-04-15 | Haefner Paul A. | Automatic detection of defibrillation lead |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| US7572237B2 (en) | 2002-11-06 | 2009-08-11 | Abbott Diabetes Care Inc. | Automatic biological analyte testing meter with integrated lancing device and methods of use |
| US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
| US20050038680A1 (en) * | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
| US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
| KR100485840B1 (en) * | 2003-01-15 | 2005-04-28 | 삼성전자주식회사 | Detecting method for life span of transferring roller and photoelectric image forming apparatus using the same |
| US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
| US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
| US20040254433A1 (en) | 2003-06-12 | 2004-12-16 | Bandis Steven D. | Sensor introducer system, apparatus and method |
| US7510564B2 (en) | 2003-06-27 | 2009-03-31 | Abbott Diabetes Care Inc. | Lancing device |
| US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US7074307B2 (en) | 2003-07-25 | 2006-07-11 | Dexcom, Inc. | Electrode systems for electrochemical sensors |
| US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7424318B2 (en) | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7108778B2 (en) | 2003-07-25 | 2006-09-19 | Dexcom, Inc. | Electrochemical sensors including electrode systems with increased oxygen generation |
| EP1648298A4 (en) | 2003-07-25 | 2010-01-13 | Dexcom Inc | Oxygen enhancing membrane systems for implantable devices |
| US7467003B2 (en) | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US20050176136A1 (en) | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
| US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| US6931327B2 (en) | 2003-08-01 | 2005-08-16 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US20080119703A1 (en) | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
| US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
| US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
| US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US20050090607A1 (en) | 2003-10-28 | 2005-04-28 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
| US6928380B2 (en) | 2003-10-30 | 2005-08-09 | International Business Machines Corporation | Thermal measurements of electronic devices during operation |
| US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
| US20080197024A1 (en) | 2003-12-05 | 2008-08-21 | Dexcom, Inc. | Analyte sensor |
| US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
| US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
| US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| WO2005057168A2 (en) | 2003-12-05 | 2005-06-23 | Dexcom, Inc. | Calibration techniques for a continuous analyte sensor |
| US20080200788A1 (en) | 2006-10-04 | 2008-08-21 | Dexcorn, Inc. | Analyte sensor |
| US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
| EP1711802B1 (en) | 2003-12-08 | 2010-07-14 | DexCom, Inc. | Systems and methods for improving electrochemical analyte sensors |
| WO2005057175A2 (en) | 2003-12-09 | 2005-06-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| US7637868B2 (en) | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
| US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
| US7364592B2 (en) | 2004-02-12 | 2008-04-29 | Dexcom, Inc. | Biointerface membrane with macro-and micro-architecture |
| WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
| US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| CA2560323C (en) | 2004-03-22 | 2014-01-07 | Bodymedia, Inc. | Non-invasive temperature monitoring device |
| JP2007535974A (en) | 2004-03-26 | 2007-12-13 | ノボ・ノルデイスク・エー／エス | Display device for related data of diabetic patients |
| US6971274B2 (en) | 2004-04-02 | 2005-12-06 | Sierra Instruments, Inc. | Immersible thermal mass flow meter |
| US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
| US20050245799A1 (en) | 2004-05-03 | 2005-11-03 | Dexcom, Inc. | Implantable analyte sensor |
| US7118667B2 (en) | 2004-06-02 | 2006-10-10 | Jin Po Lee | Biosensors having improved sample application and uses thereof |
| JP2006005774A (en) | 2004-06-18 | 2006-01-05 | Alps Electric Co Ltd | Communication terminal device |
| US7623988B2 (en) | 2004-06-23 | 2009-11-24 | Cybiocare Inc. | Method and apparatus for the monitoring of clinical states |
| US20060001538A1 (en) | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Methods of monitoring the concentration of an analyte |
| US20060015020A1 (en) | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
| US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US20060270922A1 (en) | 2004-07-13 | 2006-11-30 | Brauker James H | Analyte sensor |
| US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
| US20080242961A1 (en) | 2004-07-13 | 2008-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
| US8313433B2 (en) | 2004-08-06 | 2012-11-20 | Medtronic Minimed, Inc. | Medical data management system and process |
| JP5032321B2 (en) | 2004-08-31 | 2012-09-26 | ライフスキャン・スコットランド・リミテッド | Manufacturing method of automatic calibration sensor |
| EP1669020A1 (en) | 2004-12-07 | 2006-06-14 | Roche Diagnostics GmbH | Storage case with integrated functions |
| US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
| US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
| US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US20070027381A1 (en) | 2005-07-29 | 2007-02-01 | Therasense, Inc. | Inserter and methods of use |
| US20060166629A1 (en) | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
| US20060173260A1 (en) | 2005-01-31 | 2006-08-03 | Gmms Ltd | System, device and method for diabetes treatment and monitoring |
| US7547281B2 (en) | 2005-02-01 | 2009-06-16 | Medtronic Minimed, Inc. | Algorithm sensor augmented bolus estimator for semi-closed loop infusion system |
| US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
| AU2006222889A1 (en) | 2005-03-15 | 2006-09-21 | Entelos, Inc. | Apparatus and method for computer modeling type 1 diabetes |
| WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
| US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
| US7806854B2 (en) | 2005-05-13 | 2010-10-05 | Trustees Of Boston University | Fully automated control system for type 1 diabetes |
| TWI265677B (en) | 2005-06-01 | 2006-11-01 | Bionime Corp | Coding module, bio measuring meter and system for operating bio measuring meter |
| US20070033074A1 (en) * | 2005-06-03 | 2007-02-08 | Medtronic Minimed, Inc. | Therapy management system |
| US20060272652A1 (en) | 2005-06-03 | 2006-12-07 | Medtronic Minimed, Inc. | Virtual patient software system for educating and treating individuals with diabetes |
| US7717342B2 (en) * | 2005-08-26 | 2010-05-18 | Hand Held Products, Inc. | Data collection device having dynamic access to multiple wireless networks |
| US9072476B2 (en) | 2005-09-23 | 2015-07-07 | Medtronic Minimed, Inc. | Flexible sensor apparatus |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
| US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
| EP3064236B1 (en) | 2005-11-08 | 2020-02-05 | Bigfoot Biomedical, Inc. | Method and system for manual and autonomous control of an infusion pump |
| US20070173706A1 (en) | 2005-11-11 | 2007-07-26 | Isense Corporation | Method and apparatus for insertion of a sensor |
| WO2007062173A1 (en) | 2005-11-22 | 2007-05-31 | Vocollect Healthcare Systems, Inc. | Advanced diabetes management system (adms) |
| US8515518B2 (en) | 2005-12-28 | 2013-08-20 | Abbott Diabetes Care Inc. | Analyte monitoring |
| EP1968432A4 (en) | 2005-12-28 | 2009-10-21 | Abbott Diabetes Care Inc | Medical device insertion |
| US8160670B2 (en) | 2005-12-28 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent |
| US20070179349A1 (en) | 2006-01-19 | 2007-08-02 | Hoyme Kenneth P | System and method for providing goal-oriented patient management based upon comparative population data analysis |
| US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
| EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
| US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
| US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
| US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
| US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
| US20080071158A1 (en) | 2006-06-07 | 2008-03-20 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
| US9056165B2 (en) | 2006-09-06 | 2015-06-16 | Medtronic Minimed, Inc. | Intelligent therapy recommendation algorithm and method of using the same |
| US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
| US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
| US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
| US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
| US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
| US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
| CN102772212A (en) | 2006-10-26 | 2012-11-14 | 雅培糖尿病护理公司 | Method, device and system for detection of sensitivity decline in analyte sensors |
| US20080154513A1 (en) | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
| US10154804B2 (en) | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
| CA2683962C (en) | 2007-04-14 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| WO2008128210A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
| WO2009096992A1 (en) | 2007-04-14 | 2009-08-06 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
| EP2146624B1 (en) | 2007-04-14 | 2020-03-25 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
| US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US20080312845A1 (en) | 2007-05-14 | 2008-12-18 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US20080306444A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US20090036760A1 (en) | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
| US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
| US9968742B2 (en) | 2007-08-29 | 2018-05-15 | Medtronic Minimed, Inc. | Combined sensor and infusion set using separated sites |
| US20090063402A1 (en) | 2007-08-31 | 2009-03-05 | Abbott Diabetes Care, Inc. | Method and System for Providing Medication Level Determination |
| US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
| US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8290559B2 (en) | 2007-12-17 | 2012-10-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US20090164190A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Physiological condition simulation device and method |
| US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
| WO2009097450A1 (en) | 2008-01-30 | 2009-08-06 | Dexcom. Inc. | Continuous cardiac marker sensor system |
| WO2009105337A2 (en) | 2008-02-20 | 2009-08-27 | Dexcom, Inc. | Continuous medicament sensor system for in vivo use |
| CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
| US20090242399A1 (en) | 2008-03-25 | 2009-10-01 | Dexcom, Inc. | Analyte sensor |
| US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
| EP3387993A3 (en) | 2008-03-28 | 2018-11-14 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
-
2008
- 2008-02-14 US US12/031,664 patent/US8121857B2/en not_active Expired - Fee Related
- 2008-02-15 EP EP20080730045 patent/EP2112905A2/en not_active Withdrawn
- 2008-02-15 RU RU2009134334/14A patent/RU2499555C2/en not_active IP Right Cessation
- 2008-02-15 WO PCT/US2008/054165 patent/WO2008101211A2/en active Application Filing
- 2008-02-15 BR BRPI0807499 patent/BRPI0807499A2/en not_active IP Right Cessation
- 2008-02-15 CA CA 2677716 patent/CA2677716A1/en not_active Abandoned
- 2008-02-15 CN CN2008800051491A patent/CN101610718B/en not_active Expired - Fee Related
-
2012
- 2012-02-17 US US13/400,026 patent/US8417545B2/en not_active Expired - Fee Related
-
2013
- 2013-04-08 US US13/858,562 patent/US8676601B2/en not_active Expired - Fee Related
-
2014
- 2014-03-17 US US14/216,872 patent/US20140200917A1/en not_active Abandoned
-
2015
- 2015-01-08 US US14/592,689 patent/US20150120323A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019974A (en) * | 1987-05-01 | 1991-05-28 | Diva Medical Systems Bv | Diabetes management system and apparatus |
| US5673322A (en) * | 1996-03-22 | 1997-09-30 | Bell Communications Research, Inc. | System and method for providing protocol translation and filtering to access the world wide web from wireless or low-bandwidth networks |
| US6144922A (en) * | 1997-10-31 | 2000-11-07 | Mercury Diagnostics, Incorporated | Analyte concentration information collection and communication system |
| US6925393B1 (en) * | 1999-11-18 | 2005-08-02 | Roche Diagnostics Gmbh | System for the extrapolation of glucose concentration |
Also Published As
| Publication number | Publication date |
|---|---|
| US8676601B2 (en) | 2014-03-18 |
| US20140200917A1 (en) | 2014-07-17 |
| US8417545B2 (en) | 2013-04-09 |
| CN101610718A (en) | 2009-12-23 |
| WO2008101211A2 (en) | 2008-08-21 |
| RU2499555C2 (en) | 2013-11-27 |
| RU2009134334A (en) | 2011-03-20 |
| US20130297334A1 (en) | 2013-11-07 |
| EP2112905A2 (en) | 2009-11-04 |
| US8121857B2 (en) | 2012-02-21 |
| US20150120323A1 (en) | 2015-04-30 |
| WO2008101211A3 (en) | 2008-10-09 |
| CA2677716A1 (en) | 2008-08-21 |
| US20120150556A1 (en) | 2012-06-14 |
| US20080201169A1 (en) | 2008-08-21 |
| BRPI0807499A2 (en) | 2014-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101610718B (en) | Device and method for automatic data acquisition and/or detection | |
| US10617823B2 (en) | Device and method for automatic data acquisition and/or detection | |
| US20240000348A1 (en) | Multi-function analyte monitor device and methods of use | |
| US20080004601A1 (en) | Analyte Monitoring and Therapy Management System and Methods Therefor | |
| US20190298259A1 (en) | Systems and methods for leveraging smartphone features in continuous glucose monitoring | |
| CN102300501B (en) | Multi-function analyte test device and methods therefor | |
| US9717845B2 (en) | Geofencing for medical devices | |
| RU2297173C2 (en) | Method and device for wireless data control between two portable medical devices | |
| CN101610714A (en) | Be used for the Apparatus and method for that automaticdata obtains and/or detects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131002 Termination date: 20150215 |
|
| EXPY | Termination of patent right or utility model |